Results affirm expectation of a novel mechanism of action targeting astrocyte activation to delay progression of Alzheimer’s disease from early stage Mild Cognitive Impairment Findings echo previous ...

Vaccinex (VCNX) provided an update on new clinical findings from its SIGNAL-AD Phase 1b/2 trial of pepinemab antibody in Alzheimer’s disease. Vaccinex recently announced results of the phase 1b/2 ...

Ad Signal, a specialist provider of video content management solutions, has partnered with Perifery to provide media organisations with seamless deduplication workflows. The integration optimises the ...